144 related articles for article (PubMed ID: 11045609)
1. Methionine oxidation within the cerebroside-sulfate activator protein (CSAct or Saposin B).
Whitelegge JP; Penn B; To T; Johnson J; Waring A; Sherman M; Stevens RL; Fluharty CB; Faull KF; Fluharty AL
Protein Sci; 2000 Sep; 9(9):1618-30. PubMed ID: 11045609
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a recombinant molecule covalently indistinguishable from human cerebroside-sulfate activator protein (CSAct or Saposin B).
Whitelegge JP; Ahn V; Norris AJ; Sung H; Waring A; Stevens RL; Fluharty CB; Prive G; Faull KF; Fluharty AL
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):799-807. PubMed ID: 14528917
[TBL] [Abstract][Full Text] [Related]
3. Preparation of the cerebroside sulfate activator (CSAct or saposin B) from human urine.
Fluharty AL; Lombardo C; Louis A; Stevens RL; Whitelegge J; Waring AJ; To T; Fluharty CB; Faull KF
Mol Genet Metab; 1999 Nov; 68(3):391-403. PubMed ID: 10562467
[TBL] [Abstract][Full Text] [Related]
4. Disulfide connectivity in cerebroside sulfate activator is not necessary for biological activity or alpha-helical content but is necessary for trypsin resistance and strong ligand binding.
Faull KF; Higginson J; Waring AJ; Johnson J; To T; Whitelegge JP; Stevens RL; Fluharty CB; Fluharty AL
Arch Biochem Biophys; 2000 Apr; 376(2):266-74. PubMed ID: 10775412
[TBL] [Abstract][Full Text] [Related]
5. A novel mass spectrometric assay for the cerebroside sulfate activator protein (saposin B) and arylsulfatase A.
Norris AJ; Whitelegge JP; Yaghoubian A; Alattia JR; Privé GG; Toyokuni T; Sun H; Brooks MN; Panza L; Matto P; Compostella F; Remmel N; Klingenstein R; Sandhoff K; Fluharty C; Fluharty A; Faull KF
J Lipid Res; 2005 Oct; 46(10):2254-64. PubMed ID: 16061947
[TBL] [Abstract][Full Text] [Related]
6. Cerebroside sulfate activator protein (Saposin B): chromatographic and electrospray mass spectrometric properties.
Faull KF; Whitelegge JP; Higginson J; To T; Johnson J; Krutchinsky AN; Standing KG; Waring AJ; Stevens RL; Fluharty CB; Fluharty AL
J Mass Spectrom; 1999 Oct; 34(10):1040-54. PubMed ID: 10510427
[TBL] [Abstract][Full Text] [Related]
7. Porcine cerebroside sulfate activator (saposin B) secondary structure: CD, FTIR, and NMR studies.
Waring AJ; Chen Y; Faull KF; Stevens R; Sherman MA; Fluharty AL
Mol Genet Metab; 1998 Jan; 63(1):14-25. PubMed ID: 9538512
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen-deuterium exchange signature of porcine cerebroside sulfate activator protein.
Faull KF; Higginson J; Waring AJ; To T; Whitelegge JP; Stevens RL; Fluharty CB; Fluharty AL
J Mass Spectrom; 2000 Mar; 35(3):392-401. PubMed ID: 10767769
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification, crystallization, and preliminary X-ray analysis of recombinant human saposin B.
Ahn VE; Faull KF; Whitelegge JP; Higginson J; Fluharty AL; Privé GG
Protein Expr Purif; 2003 Jan; 27(1):186-93. PubMed ID: 12510003
[TBL] [Abstract][Full Text] [Related]
10. The cerebroside sulfate activator from pig kidney: purification and molecular structure.
Fluharty AL; Katona Z; Meek WE; Frei K; Fowler AV
Biochem Med Metab Biol; 1992 Feb; 47(1):66-85. PubMed ID: 1562358
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
12. The effect of carbohydrate removal on stability and activity of saposin B.
Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
[TBL] [Abstract][Full Text] [Related]
13. Porcine cerebroside sulfate activator: further structural characterization and disulfide identification.
Stevens RL; Faull KF; Conklin KA; Green BN; Fluharty AL
Biochemistry; 1993 Apr; 32(15):4051-9. PubMed ID: 8471613
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C.
Weiler S; Carson W; Lee Y; Teplow DB; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM
J Mol Neurosci; 1993; 4(3):161-72. PubMed ID: 8292489
[TBL] [Abstract][Full Text] [Related]
15. Comparative lipid binding study on the cerebroside sulfate activator (saposin B).
Fluharty CB; Johnson J; Whitelegge J; Faull KF; Fluharty AL
J Neurosci Res; 2001 Jan; 63(1):82-9. PubMed ID: 11169617
[TBL] [Abstract][Full Text] [Related]
16. Structure of the asparagine-linked sugar chains of porcine kidney and human urine cerebroside sulfate activator protein.
Faull KF; Johnson J; Kim MJ; To T; Whitelegge JP; Stevens RL; Fluharty CB; Fluharty AL
J Mass Spectrom; 2000 Dec; 35(12):1416-24. PubMed ID: 11180632
[TBL] [Abstract][Full Text] [Related]
17. Repair of oxidized calmodulin by methionine sulfoxide reductase restores ability to activate the plasma membrane Ca-ATPase.
Sun H; Gao J; Ferrington DA; Biesiada H; Williams TD; Squier TC
Biochemistry; 1999 Jan; 38(1):105-12. PubMed ID: 9890888
[TBL] [Abstract][Full Text] [Related]
18. Transepithelially transported pro-phenoloxidase in the cuticle of the silkworm, Bombyx mori. Identification of its methionyl residues oxidized to methionine sulfoxides.
Asano T; Ashida M
J Biol Chem; 2001 Apr; 276(14):11113-25. PubMed ID: 11116145
[TBL] [Abstract][Full Text] [Related]
19. Combined application of high resolution and tandem mass spectrometers to characterize methionine oxidation in a parathyroid hormone formulation.
Pan C; Valente JJ; LoBrutto R; Pickett JS; Motto M
J Pharm Sci; 2010 Mar; 99(3):1169-79. PubMed ID: 19711445
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of saposin B reveals a dimeric shell for lipid binding.
Ahn VE; Faull KF; Whitelegge JP; Fluharty AL; Privé GG
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):38-43. PubMed ID: 12518053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
